- Investing Ideas
- Japanese Biotech Breakthroughs
Japanese Biotech Breakthroughs
Results
3
0 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
3 companies
GNI Group
Market Cap: JP¥174.5b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥3,115.00
7D
-9.4%
1Y
36.5%
Healios K.K
Market Cap: JP¥47.0b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥342.00
7D
-10.2%
1Y
6.9%
SanBio
Market Cap: JP¥159.8b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system.
4592
JP¥2,006.00
7D
-8.1%
1Y
-0.5%